Skip to main content

Advertisement

Fig. 2 | Journal of Experimental Orthopaedics

Fig. 2

From: Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates

Fig. 2

Mean percent changes from baseline in lumbar spine and hip BMDs. Naive group: treatment-naïve group; switch group: transitioning from bisphosphonate group; BMD: bone mineral density; FN: femoral neck; TH: total hip. P values from Mann-Whitney U tests, for the mean percent change from baseline in the naive group versus the switch group. n.s denotes no significant difference between the values

Back to article page